Jaret Malloy

Summary

Affiliation: Amylin Pharmaceuticals
Country: USA

Publications

  1. pmc Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes
    Jaret Malloy
    Amylin Pharmaceuticals LLC, San Diego, CA, USA
    Diabetes Metab Syndr Obes 5:419-24. 2012
  2. doi Efficacy and tolerability of exenatide once weekly versus sitagliptin in patients with type 2 diabetes mellitus: a retrospective analysis of pooled clinical trial data
    Jaret Malloy
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Postgrad Med 125:58-67. 2013
  3. doi Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study
    Jaret Malloy
    Amylin Pharmaceuticals, Inc, San Diego, California 92121, USA
    Clin Ther 31:806-15. 2009
  4. pmc Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment
    Jennie H Best
    Medical Development, Amylin Pharmaceuticals, San Diego, California, USA
    Diabetes Care 34:314-9. 2011
  5. doi Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials
    Michael Grimm
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Postgrad Med 125:47-57. 2013

Collaborators

Detail Information

Publications5

  1. pmc Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes
    Jaret Malloy
    Amylin Pharmaceuticals LLC, San Diego, CA, USA
    Diabetes Metab Syndr Obes 5:419-24. 2012
    ..Serum lipase and pancreatic amylase concentrations are used in conjunction with clinical findings to diagnose pancreatitis...
  2. doi Efficacy and tolerability of exenatide once weekly versus sitagliptin in patients with type 2 diabetes mellitus: a retrospective analysis of pooled clinical trial data
    Jaret Malloy
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Postgrad Med 125:58-67. 2013
    ....
  3. doi Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study
    Jaret Malloy
    Amylin Pharmaceuticals, Inc, San Diego, California 92121, USA
    Clin Ther 31:806-15. 2009
    ..This study assessed the pharmacokinetics, pharmacodynamics, and tolerability of single doses of exenatide in adolescent patients with type 2 diabetes mellitus (T2DM)...
  4. pmc Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment
    Jennie H Best
    Medical Development, Amylin Pharmaceuticals, San Diego, California, USA
    Diabetes Care 34:314-9. 2011
    ..To assess change in patient-reported outcomes in subjects with type 2 diabetes treated with exenatide once weekly compared with those treated with sitagliptin or pioglitazone...
  5. doi Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials
    Michael Grimm
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Postgrad Med 125:47-57. 2013
    ..This post hoc analysis pooled data from patients taking EQW across 6 trials to assess efficacy and safety in a large, varied patient population...